The present invention relates to novel uses of cyclodextrins either separatelyor in combination with beta glucans, to reduce trans fat levels in foodproducts and food intermediates, as well as to enhance the hypocholesterolemicand hypocaloric benefit either individually or synergistically with othercomponents.